Product Information

PHENOBARBITAL 64.8 MG TABLET is a generic product labeled by e5 Pharma, LLC, priced at $0.0963 per EA under NDC 13517062710. Its NADAC has been published 198 times since Feb 8, 2023.

PHENOBARBITAL 64.8 MG TABLET

phenobarbital
$0.0963per EA
Discontinued
DEA Schedule CIV

Strength

64.8 mg/1

Manufacturer

e5 Pharma, LLC

NDC

13517062710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PHENOBARBITAL

Approval Type

Unapproved

On Market Since

11/30/2022

Price Statistics

The NADAC for PHENOBARBITAL 64.8 MG TABLET has been published 198 times since Feb 8, 2023, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0963 per EA
All-time high$0.3176 (Aug 16, 2023)
All-time low$0.0928 (Jul 22, 2026)
52-week high$0.1433
52-week low$0.0928
Median price$0.1490
Average price$0.1725
Largest weekly change+98.1% (Aug 21, 2024)
Weeks tracked198
Tracking sinceFeb 8, 2023

Price History

1W

-4.8%

1M

-5.2%

3M

-0.8%

6M

-9.4%

1Y

-32.8%

3Y

-62.0%

5Y

N/A

All

-69.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PHENOBARBITAL 64.8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 64.8 MG TABLET, manufactured by e5 Pharma, LLC, is $0.0963 per EA (NDC 13517062710), effective Nov 18, 2026.

How has the price of PHENOBARBITAL 64.8 MG TABLET changed over time?

Over the history we have for it, the NADAC for PHENOBARBITAL 64.8 MG TABLET has declined 69.2%. It has been tracked across 198 weekly CMS publications since Feb 8, 2023.

What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 64.8 MG TABLET?

Since Feb 8, 2023, the NADAC for PHENOBARBITAL 64.8 MG TABLET has ranged from a low of $0.0928 (Jul 22, 2026) to a high of $0.3176 (Aug 16, 2023), with a median of $0.1490 per EA.

Are there cheaper alternatives to PHENOBARBITAL 64.8 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENOBARBITAL 64.8 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PHENOBARBITAL 64.8 MG TABLET?

PHENOBARBITAL 64.8 MG TABLET (NDC 13517062710) is labeled by e5 Pharma, LLC, and CMS classifies it as a generic product.